global medical manufacturer since 1973 celebrating 50 years

UPCOMING
EVENTS
  • April 8

    ABA 2025

    Dates: 08 – 11 Apr, 2025 | Phoenix
  • April 10

    Abu Dhabi

    Dates: 10 – 11 Apr, 2025 | Al Rawdah - Al Ma'arid
  • April 18

    Closed Good Friday

    Dates: 17 – 18 Apr, 2025 | Powell
  • April 23

    TraumaCon

    Dates: 23 – 25 Apr, 2025 | Kansas City
  • April 30

    SAWC Spring

    Dates: 30 Apr – 05 May, 2025 | Grapevine
  • May 2

    AATS

    Dates: 02 – 05 May, 2025 | Seattle

A-View® Endotracheal Balloon Catheter wins "Diagnostics for Prevention" at the Healthtech Ireland Innovation Awards 2022

by DeRoyal News | Nov 28, 2022
A-View® Endotracheal Balloon Catheter won an award at the Healthtech Ireland Innovation Awards 2022 in the category of "Diagnostics for Prevention."

We are delighted to announce that last night the A-View® Endotracheal Balloon Catheter won an award at the Healthtech Ireland Innovation Awards in the category of "Diagnostics for Prevention."


HealthTech-Sqare-1024x1024The awards were held at the famous Mansion House building in Dublin, Ireland and attended by: Michael Corcoran (DeRoyal International Global Business Development Manager), Mario Gaztambide (DeRoyal VP International), Dr. Arno Nierich (Inventor of A-View®), Dermot Dempster (Clonallon Laboratories LTD Managing Director), and Siobhan Southwell (Affidea Ireland). See the full Award list here »

A-View Healthtech Ireland Innovation Award

Receiving the Award: Michael Corcoran, Mario Gaztambide, Dr. Arno Nierich, Dermot Demptster, Siobhan Southwell.

 

A-View wins at HIIA 2022

Left to Right: Dr. Arno Nierich, Michael Corcoran, Mario Gaztambide, and Dermot Demptster.

 


A-View® Endotracheal Balloon Catheter

A-View-5-lighter

The A-View® balloon provides complete visualization of the distal ascending aorta during TEE, thus eliminating the 'blind spot'. This is accomplished by filling the air-void within the trachea with a saline-filled balloon, allowing for a complete diagnosis of dangerous plaques at risk for potential dislodgement prior to CPB cannulation and aortic cross clamping. The A-View® balloon has been proven to reduce the risk of periprocedural stroke by 30%*.

 

contact us: